目的探讨德谷门冬双胰岛素与门冬胰岛素持续皮下输注在院内非内分泌科住院的糖尿病患者中治疗的有效性及安全性。方法回顾性分析2021年12月至2022年6月于郑州大学第五附属医院非内分泌科住院应用门冬胰岛素30注射液但血糖不达标的糖尿...目的探讨德谷门冬双胰岛素与门冬胰岛素持续皮下输注在院内非内分泌科住院的糖尿病患者中治疗的有效性及安全性。方法回顾性分析2021年12月至2022年6月于郑州大学第五附属医院非内分泌科住院应用门冬胰岛素30注射液但血糖不达标的糖尿病患者82例,其中调整为德谷门冬双胰岛素治疗50例(德谷门冬组),调整为胰岛素泵持续皮下输注门冬胰岛素治疗组32例(胰岛素泵组)。分析两组一般特征,治疗前后血糖、胰岛素用量变化,血糖达标时间,血糖在目标范围内的时间,血糖波动指标[平均血糖波动幅度(mean amplitude of glycemic excursion,MAGE)、血糖标准差(standard deviation of blood glucose,SDBG)、最大血糖波动幅度、日间血糖平均绝对差(absolute means of daily difference,MODD)],血糖达标时胰岛素用量,低血糖发生情况,患者及相关科室医生满意度等。结果治疗10天后两组血糖均明显下降,胰岛素用量均较治疗前明显减少(P<0.05);空腹血糖、治疗前后血糖变化、胰岛素用量变化、医生满意度两组差异无统计学意义(P>0.05);德谷门冬组低血糖发生率较低、患者满意度较高,两组差异有统计学意义(P<0.01);德谷门冬组SDBG、MAGE、MODD、血糖达标时间劣于胰岛素泵组,差异有统计学意义(P<0.05)。结论在非内分泌科住院的糖尿病患者中,德谷门冬双胰岛素与门冬胰岛素持续皮下输注均能有效控制血糖达标,节约胰岛素用量;德谷门冬胰岛素低血糖风险更低,患者满意度更高,但血糖达标时间较长、血糖波动较大。展开更多
目的探讨在硬膜外麻醉下靶控输注(target-controlled infusion,TCI)异丙酚镇静下,皮肤电传导率(skin conductance,SC)在监测意识状态的应用。方法择期硬膜外麻醉骨科手术患者30例,年龄22~47岁,体重51~83 kg,美国麻醉医师协会(The A...目的探讨在硬膜外麻醉下靶控输注(target-controlled infusion,TCI)异丙酚镇静下,皮肤电传导率(skin conductance,SC)在监测意识状态的应用。方法择期硬膜外麻醉骨科手术患者30例,年龄22~47岁,体重51~83 kg,美国麻醉医师协会(The American Society of Anesthesiologists,ASA)分级Ⅰ~Ⅱ级,无术前用药,无心、肺疾病,无气道通气障碍;硬膜外麻醉起效后,用异丙酚输注泵靶控异丙酚,以0.6μg/ml为初始浓度,以0.6μg/ml递增,直至改良镇静警醒(OAA/S)评分≤2级,停止靶控输注,患者逐步恢复意识,直至OAA/S评分恢复至5级,每3分钟评价OAA/S评分,同时记录SC、MAP和HR。结果 SC能较好地反映病人镇静时的意识状态(P〈0.01);OAA/S评分与SC有显著相关性,r为-0.859(P〈0.01),明显好于MAP和HR。结论 SC能正确反映靶控输注异丙酚镇静时的镇静深度。展开更多
AIM:To describe baseline data of the optimal type2 diabetes management including benchmarking and standard treatment(OPTIMISE)study in Greece.METHODS:"Benchmarking"is the process of receiving feedback compar...AIM:To describe baseline data of the optimal type2 diabetes management including benchmarking and standard treatment(OPTIMISE)study in Greece.METHODS:"Benchmarking"is the process of receiving feedback comparing one’s performance with that of others.The OPTIMISE(NCT00681850)study is a multinational,multicenter study assessing,at a primary care level,whether using"benchmarking"can help to improve the quality of patient care,compared with a set of guideline-based reference values("non-benchmarking").In the Greek region,797 outpatients(457men,mean age 63.8 years)with type 2 diabetes were enrolled by 84 office-based physicians.Baseline characteristics of this population are presented.RESULTS:Hypertension was the most prevalent concomitant disorder(77.3%)and coronary heart disease was the most frequent macrovascular complication of diabetes(23.8%).Most patients were overweight or obese(body mass index 29.6±5 kg/m2),exhibiting mostly abdominal obesity(waist circumference102.6±13.6 cm).Biguanides were the most prevalent prescribed drugs for the management of diabetes(70.1%of all prescriptions),whereas statins(93.5%of all prescriptions)and angiotensin receptor blockers(55.8%of all prescriptions)were the most prevalent prescribed drugs for hyperlipidemia and hypertension,respectively.Only 37.4%of patients were on aspirin.Despite treatment,pre-defined targets for fasting plasma glucose(<110 mg/dL),glycated hemoglobin(<7%),systolic blood pressure(<130 mmHg and<125mmHg for patients with proteinuria)and low density lipoprotein cholesterol levels(<100 mg/dL and<70mg/dL for patients with coronary heart disease)were reached in a relatively small proportion of patients(29%,53%,27%and 31%,respectively).In a Greek population with type 2 diabetes,the control of glycemia or concomitant disorders which increase cardiovascular risk remains poor.CONCLUSION:Despite relevant treatment,there is a poor control of diabetes,hypertension and hyperlipidemia in Greek outpatients with type 2 diabetes.展开更多
文摘目的探讨德谷门冬双胰岛素与门冬胰岛素持续皮下输注在院内非内分泌科住院的糖尿病患者中治疗的有效性及安全性。方法回顾性分析2021年12月至2022年6月于郑州大学第五附属医院非内分泌科住院应用门冬胰岛素30注射液但血糖不达标的糖尿病患者82例,其中调整为德谷门冬双胰岛素治疗50例(德谷门冬组),调整为胰岛素泵持续皮下输注门冬胰岛素治疗组32例(胰岛素泵组)。分析两组一般特征,治疗前后血糖、胰岛素用量变化,血糖达标时间,血糖在目标范围内的时间,血糖波动指标[平均血糖波动幅度(mean amplitude of glycemic excursion,MAGE)、血糖标准差(standard deviation of blood glucose,SDBG)、最大血糖波动幅度、日间血糖平均绝对差(absolute means of daily difference,MODD)],血糖达标时胰岛素用量,低血糖发生情况,患者及相关科室医生满意度等。结果治疗10天后两组血糖均明显下降,胰岛素用量均较治疗前明显减少(P<0.05);空腹血糖、治疗前后血糖变化、胰岛素用量变化、医生满意度两组差异无统计学意义(P>0.05);德谷门冬组低血糖发生率较低、患者满意度较高,两组差异有统计学意义(P<0.01);德谷门冬组SDBG、MAGE、MODD、血糖达标时间劣于胰岛素泵组,差异有统计学意义(P<0.05)。结论在非内分泌科住院的糖尿病患者中,德谷门冬双胰岛素与门冬胰岛素持续皮下输注均能有效控制血糖达标,节约胰岛素用量;德谷门冬胰岛素低血糖风险更低,患者满意度更高,但血糖达标时间较长、血糖波动较大。
文摘目的探讨在硬膜外麻醉下靶控输注(target-controlled infusion,TCI)异丙酚镇静下,皮肤电传导率(skin conductance,SC)在监测意识状态的应用。方法择期硬膜外麻醉骨科手术患者30例,年龄22~47岁,体重51~83 kg,美国麻醉医师协会(The American Society of Anesthesiologists,ASA)分级Ⅰ~Ⅱ级,无术前用药,无心、肺疾病,无气道通气障碍;硬膜外麻醉起效后,用异丙酚输注泵靶控异丙酚,以0.6μg/ml为初始浓度,以0.6μg/ml递增,直至改良镇静警醒(OAA/S)评分≤2级,停止靶控输注,患者逐步恢复意识,直至OAA/S评分恢复至5级,每3分钟评价OAA/S评分,同时记录SC、MAP和HR。结果 SC能较好地反映病人镇静时的意识状态(P〈0.01);OAA/S评分与SC有显著相关性,r为-0.859(P〈0.01),明显好于MAP和HR。结论 SC能正确反映靶控输注异丙酚镇静时的镇静深度。
文摘AIM:To describe baseline data of the optimal type2 diabetes management including benchmarking and standard treatment(OPTIMISE)study in Greece.METHODS:"Benchmarking"is the process of receiving feedback comparing one’s performance with that of others.The OPTIMISE(NCT00681850)study is a multinational,multicenter study assessing,at a primary care level,whether using"benchmarking"can help to improve the quality of patient care,compared with a set of guideline-based reference values("non-benchmarking").In the Greek region,797 outpatients(457men,mean age 63.8 years)with type 2 diabetes were enrolled by 84 office-based physicians.Baseline characteristics of this population are presented.RESULTS:Hypertension was the most prevalent concomitant disorder(77.3%)and coronary heart disease was the most frequent macrovascular complication of diabetes(23.8%).Most patients were overweight or obese(body mass index 29.6±5 kg/m2),exhibiting mostly abdominal obesity(waist circumference102.6±13.6 cm).Biguanides were the most prevalent prescribed drugs for the management of diabetes(70.1%of all prescriptions),whereas statins(93.5%of all prescriptions)and angiotensin receptor blockers(55.8%of all prescriptions)were the most prevalent prescribed drugs for hyperlipidemia and hypertension,respectively.Only 37.4%of patients were on aspirin.Despite treatment,pre-defined targets for fasting plasma glucose(<110 mg/dL),glycated hemoglobin(<7%),systolic blood pressure(<130 mmHg and<125mmHg for patients with proteinuria)and low density lipoprotein cholesterol levels(<100 mg/dL and<70mg/dL for patients with coronary heart disease)were reached in a relatively small proportion of patients(29%,53%,27%and 31%,respectively).In a Greek population with type 2 diabetes,the control of glycemia or concomitant disorders which increase cardiovascular risk remains poor.CONCLUSION:Despite relevant treatment,there is a poor control of diabetes,hypertension and hyperlipidemia in Greek outpatients with type 2 diabetes.